Abstract |
IL-6 is a proinflammatory cytokine secreted by tumor cells and immune cells to affect the development of cancer. This study demonstrates the effects of tumor-derived IL-6 on the malignancy of tumor cells and tumor immunity. The tumor cell line, EG7, was transfected with a mammalian expression vector encoding the full length of murine IL-6 to mimic IL-6-secreting tumor cells. Two IL-6 transfectants with low and high IL-6 production were compared in vitro and in vivo. While the in vitro proliferation rates of both transfectants and the parental line were similar, high expression of IL-6 induced a significant reduction in tumor growth in vivo. Concomitantly, there was an increase in IFN-gamma positive tumor-infiltrating lymphocytes and a decrease in the suppressive CD4(+)CD25(+)FoxP3(+) population. These results demonstrate the direct effects of tumor-derived IL-6 on cancer development and the induction of tumor immunity.
|
Authors | Chia-Ling Hsieh, Shih-Jen Liu, Chia-Rui Shen, Mei-Yu Chen, Shu-Ching Hsu, Jy-Ping Tsai, Yi-Shiuan Li, Ching-Jen Yang, Pele Chong, Hsin-Wei Chen |
Journal | Immunobiology
(Immunobiology)
Vol. 215
Issue 6
Pg. 486-91
(Jun 2010)
ISSN: 1878-3279 [Electronic] Netherlands |
PMID | 19699006
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2009 Elsevier GmbH. All rights reserved. |
Chemical References |
- Interleukin-6
- Interferon-gamma
|
Topics |
- Animals
- CD4-Positive T-Lymphocytes
(immunology)
- CD8-Positive T-Lymphocytes
(immunology)
- Cell Line, Tumor
- Immunity, Cellular
(genetics, immunology)
- Interferon-gamma
(immunology)
- Interleukin-6
(genetics, immunology)
- Mice
- Mice, SCID
- Neoplasms, Experimental
(immunology, therapy)
- Transfection
|